Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties Post author:Sam Post published:February 1, 2018 Post category:BioPharma AstraZeneca did not immediately respond to a request for comment. Source: BioSpace You Might Also Like Nestle Emerges as the Frontrunner for Merck KGaA's $5B Consumer Health Biz January 9, 2018 Heads Up, Startups: Bayer AG is Bringing Its Grants4Apps Accelerator Program to San Francisco February 7, 2017 3 Biotechs That Have Doubled Investors' Money in Less Than a Year January 22, 2018
Heads Up, Startups: Bayer AG is Bringing Its Grants4Apps Accelerator Program to San Francisco February 7, 2017
